MORPHABOND ER is a single-agent

MORPHABOND ER is a single-agent, abuse-deterrent ER morphine with SentryBond technology1

However, abuse is still possible by intranasal, intravenous, and oral routes

MORPHABOND ER (morphine sulfate) extended-release tablets, for oral use, CII is an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.



Daiichi Sankyo is committed to responsible use of prescription pain medications